Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: A preliminary study

International Journal of Food Sciences and Nutrition

Volumn 61, Issue 8, 2010, Pages 792-802

  Sofi, Francesco ^a,b   Giangrandi, Ilaria ^a   Cesari, Francesca ^a,b   Corsani, Ilaria ^a   Abbate, Rosanna ^a,b   Gensini, Gian Franco ^a,b   Casini, Alessandro ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Diet; Non alcoholic fatty liver disease; Olive oil; Omega 3 fatty acids; Steatosis

Indexed keywords

ADIPONECTIN; ENZYME; OLIVE OIL; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL; VEGETABLE OIL;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; ENZYMOLOGY; FAT INTAKE; FATTY LIVER; FEMALE; HUMAN; LIVER; MALE; MIDDLE AGED; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL;

ADIPONECTIN; ADULT; AGED; DIETARY FATS; ENZYMES; FATTY ACIDS, OMEGA-3; FATTY LIVER; FEMALE; FOOD, FORTIFIED; HUMANS; LIVER; MALE; MIDDLE AGED; PILOT PROJECTS; PLANT OILS; TRIGLYCERIDES;

EID: 78649823911     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2010.487480     Document Type: Article

References (16)

1. Alwayn IP, Gura K, Nosé V, et al. 2005. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res 57:445-452.
2. Alonso A, Ruiz-Gutierrez V, Martinez-Gonzalez MA. 2006. Monounsaturated fatty acids, olive oil and blood pressure: Epidemiological, clinical and experimental evidence. Public Health Nutr 9:251-257.
3. Angulo P. 2002. Nonalcoholic fatty liver disease. N Engl J Med 346:1221-1231.
4. Assy N, Nassar F, Nasser G, Grosovski M. 2009. Olive oil consumption and non-alcoholic fatty liver disease. World J Gastroenterol 15:1809-1815.
5. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, et al. 2002. Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123:134-140.
6. Capanni M, Calella F, Biagini MR, Genise S, Raimondi L, Bedogni G, Svegliati-Baroni G, Sofi F, Milani S, Abbate R, et al. 2006. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther 23:1143-1151.
7. Hussein O, Grosovski M, Lasri E, Svalb S, Ravid U, Assy N, et al. 2007. Monounsaturated fat decrease hepatic lipid content in non-alcoholic fatty liver disease in rats. World J Gastroenterol 13:361-368.
8. Lee S, Gura Km, Puder M. 2007. Omega-3 fatty acids and liver disease. Hepatology 45:841-845.
9. Lizardi-Cervera J, Aguilar-Zapata D. 2009. Nonalcoholic fatty liver disease and its association with cardiovascular disease. Ann Hepatol 8: S40-S43.
10. Moscatello S, Marzocchi R, Villanova N. 2008. Which treatment for nonalcoholic fatty liver disease? Mini Rev Med Chem 8:767-775.
11. Oh MK, Winn J, Poordad F. 2008. Review article: Diagnosis and treatment of non-alcoholic fatty liver disease. Aliment Pharmacol Ther 28:503-522.
12. Paniagua JA, Gallego de la Sacristana A, Romero I, Vidal-Puig A, Latre JM, Sanchez E, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F. 2007. Monounsaturated fat-rich diet prevents central body fat distribution and decreases postprandial adiponectin expression induced by a carbohydrate-rich diet in insulin-resistant subjects. Diabetes Care 30:1717-1723.
13. Spadaro L, Magliocco O, Spampanato D, Piro S, Oliveri C, Alagona C, Papa G, Rabuazzo AM, Purrello F. 2008. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liver Dis 40:194-199.
14. Svegliati-Baroni G, Candelaresi C, Saccomanno S, Ferretti G, Bachetti T, Marzioni M, De Mincis S, Nobili L, Salzano R, Omenetti A, Pacetti D, et al. 2006. A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. Am J Pathol 169:846-860.
15. Wieckowska A, McCullough AJ, Feldstein AE. 2007. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 46:582-589.
16. Zhu FS, Liu S, Chen XM, Huang ZG, Zhang DM. 2008. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World J Gastroenterol 14:6395-6400.